The orthotopic transplantation model of human tumor has been demonstrated to be more patient-like animal tumor model. However, observations of tumor progression and metastasis are limited by the deep location of the colon or limited deep penetration ability of fluorescence through tissue. The purpose of this study is to establish a superficial orthotopic model to allow easier real-time visualization and more sensitive monitoring of fluorescent orthotopic colon tumor. Human colon cancer HT-29 cells were transduced with a pLPCX expression retroviral vector containing green fluorescent protein and neomycin resistance genes. For superficial orthotopic transplantation model, the cecum was identified and pulled out of the peritoneal cavity, the space between the cecum and peritoneum was sutured, the cecum was pulled to subcutaneous tissue, and incision was made on the cecal serosa followed by the implantation of a 1-mm tumor tissue to the cecum. For comparison, a conventional orthotopic transplantation model was established in a separate group of mice simultaneously. When tumor sizes reached 5 mm in diameter, half the mice in each model received 5-FU treatment. Primary tumor and metastases were monitored by fluorescent imaging or caliber measurement. Tumor fluorescence was observed as early as 3 days (median time of 4.7 ± 1.3 days) post-transplantation in the superficial orthotopic transplantation model, which was much earlier than 21 days (median time of 26.2 ± 9.9 days) in conventional orthotopic transplantation model. Although tumor growth of 5-FU-treated mice in conventional orthotopic model was lower than those of the untreated mice, the difference was not significant. However, in superficial orthotopic model, tumor growth was significantly inhibited in 5-FU-treated mice relative to the untreated mice. Fluorescence imaging showed similar metastasis incidence between the superficial and conventional orthotopic transplantation models. The fluorescent superficial orthotopic transplantation colon model allows easier real-time visualization and more sensitive monitoring of tumor growth as well as convenient repeated sampling. It is a valuable orthotopic implantation model for study of colon cancer and evaluation of new anti-cancer therapy.
[1]
M. Taketo,et al.
Mouse models of gastrointestinal tumors
,
2006,
Cancer science.
[2]
Meng Yang,et al.
Whole-body imaging with fluorescent proteins
,
2006,
Nature Protocols.
[3]
R. Hoffman.
Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
,
2005,
Methods in molecular medicine.
[4]
R. Hoffman.
Orthotopic is orthodox: Why are orthotopic‐transplant metastatic models different from all other models?
,
1994,
Journal of cellular biochemistry.
[5]
R. Hoffman.
Orthotopic Transplant Mouse Models with Green Fluorescent Protein-expressing Cancer Cells to Visualize Metastasis and Angiogenesis
,
1998,
Cancer and Metastasis Reviews.
[6]
K. Yamauchi,et al.
The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer.
,
2007,
Anticancer research.
[7]
K. Yamauchi,et al.
Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system.
,
2006,
Cancer research.
[8]
Heiying Jin,et al.
A simple colostomy implantation model for evaluating colon cancer
,
2008,
International Journal of Colorectal Disease.
[9]
Robert M. Hoffman,et al.
The multiple uses of fluorescent proteins to visualize cancer in vivo
,
2005,
Nature Reviews Cancer.
[10]
R. Gamagami,et al.
A nude mouse model of massive liver and lymph node metastasis of human colon cancer.
,
2000,
Anticancer research.